Analysen von Mark Belsey
| 07.09.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 01.08.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 30.07.18 | GSK Hold | Kepler Cheuvreux | |
| 26.04.18 | GSK Hold | Kepler Cheuvreux | |
| 28.03.18 | GSK Hold | Kepler Cheuvreux | |
| 09.02.18 | GSK Hold | Kepler Cheuvreux | |
| 06.02.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 01.11.17 | AstraZeneca buy | Kepler Cheuvreux | |
|
Werbung
|
|||
| 28.07.17 | AstraZeneca kaufen | Kepler Cheuvreux | |
| 09.03.17 | GSK Reduce | Kepler Cheuvreux | |
| 03.08.16 | GSK Neutral | UBS AG | |
| 28.07.16 | GSK Neutral | UBS AG | |
| 31.05.16 | GSK Neutral | UBS AG | |
| 17.05.16 | AstraZeneca buy | UBS AG | |
| 28.04.16 | GSK Neutral | UBS AG | |
| 28.04.16 | Novartis Neutral | UBS AG | |
| 27.04.16 | AstraZeneca buy | UBS AG | |
| 21.04.16 | Sanofi Neutral | UBS AG | |
| 21.04.16 | GSK Neutral | UBS AG | |
| 18.04.16 | Roche buy | UBS AG | |
| 15.04.16 | Novartis Neutral | UBS AG | |